🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/02/2008 | 15,05 | 15,31 | 14,45 | 14,97 | +4,17% | 5,72% | 136.869 |
| 15/02/2008 | 15,42 | 15,61 | 14,34 | 14,37 | -7,47% | 8,25% | 160.995 |
| 14/02/2008 | 15,53 | 16,24 | 14,90 | 15,53 | +0,00% | 8,67% | 190.196 |
| 13/02/2008 | 15,80 | 15,80 | 15,12 | 15,53 | -0,24% | 4,27% | 51.430 |
| 12/02/2008 | 15,16 | 15,83 | 14,86 | 15,57 | +3,23% | 6,42% | 64.815 |
| 11/02/2008 | 15,91 | 15,98 | 15,08 | 15,08 | -5,40% | 5,65% | 61.956 |
| 08/02/2008 | 15,95 | 16,24 | 15,68 | 15,95 | -0,70% | 3,52% | 114.080 |
| 07/02/2008 | 15,65 | 16,24 | 15,61 | 16,06 | +2,14% | 4,07% | 80.203 |
| 06/02/2008 | 15,80 | 16,09 | 15,53 | 15,72 | +0,24% | 3,55% | 82.875 |
| 05/02/2008 | 15,91 | 16,32 | 15,65 | 15,68 | -3,90% | 4,24% | 106.065 |
| 04/02/2008 | 16,06 | 16,47 | 15,91 | 16,32 | +1,16% | 3,50% | 65.483 |
| 01/02/2008 | 15,65 | 16,17 | 15,23 | 16,13 | +3,61% | 5,98% | 64.093 |
| 31/01/2008 | 15,35 | 16,02 | 15,27 | 15,57 | -0,72% | 4,88% | 133.877 |
| 30/01/2008 | 15,95 | 16,54 | 15,61 | 15,68 | -2,10% | 5,87% | 99.733 |
| 29/01/2008 | 16,09 | 16,21 | 15,50 | 16,02 | +0,00% | 4,42% | 65.376 |
| 28/01/2008 | 15,53 | 16,47 | 15,42 | 16,02 | +1,91% | 6,75% | 108.096 |
| 25/01/2008 | 16,43 | 16,73 | 15,35 | 15,72 | -2,78% | 8,43% | 103.741 |
| 24/01/2008 | 16,96 | 17,44 | 16,06 | 16,17 | -4,00% | 8,17% | 107.481 |
| 23/01/2008 | 16,84 | 17,52 | 16,06 | 16,84 | -2,17% | 8,67% | 134.011 |
| 22/01/2008 | 16,69 | 18,34 | 16,09 | 17,22 | -1,29% | 13,45% | 69.998 |
| 18/01/2008 | 17,40 | 17,89 | 17,18 | 17,44 | -1,48% | 4,09% | 186.509 |
| 17/01/2008 | 18,30 | 18,34 | 17,59 | 17,70 | -1,46% | 4,09% | 137.698 |
| 16/01/2008 | 17,67 | 18,38 | 17,59 | 17,97 | +1,69% | 4,45% | 689.798 |
| 15/01/2008 | 17,59 | 18,00 | 17,22 | 17,67 | -1,05% | 4,47% | 102.726 |
| 14/01/2008 | 17,52 | 18,08 | 17,48 | 17,85 | +2,80% | 3,42% | 60.460 |
| 11/01/2008 | 17,37 | 17,89 | 17,14 | 17,37 | -0,64% | 4,31% | 70.959 |
| 10/01/2008 | 17,26 | 17,97 | 16,84 | 17,48 | -0,21% | 6,51% | 76.997 |
| 09/01/2008 | 17,33 | 17,78 | 17,11 | 17,52 | +0,43% | 3,89% | 89.581 |
| 08/01/2008 | 17,52 | 17,85 | 17,37 | 17,44 | -0,21% | 2,78% | 99.600 |
| 07/01/2008 | 17,22 | 17,67 | 16,96 | 17,48 | +1,52% | 4,13% | 91.585 |